Press Releases

Pulmonary and Nasal Drug Delivery Experts to Attend RDD Europe 2019, May 7-10, Estoril, Portugal

Aptar Pharma is pleased to announce the co-organization and diamond sponsorship of the Respiratory Drug Delivery (RDD®) Europe 2019 scientific conference, which will connect pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal, May 7-10,...

Portola secures FDA approval for Andexxa generation 2 manufacturing process

The US FDA has approved Portola Pharmaceuticals’ Prior Approval Supplement (PAS) for the manufacturing process of second generation Andexxa . Andexxa received both U.S. Orphan Drug and FDA Breakthrough Therapy designations and was initially approved on...

Eisai’s New Drug Application for Perampanel Designated for Priority Review by China National Medical Products Administration

Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as an adjunctive treatment for partial onset seizures in epilepsy patients 12 years of age and...

Eisai’s New Drug Application for Perampanel Designated for Priority Review by China National Medical Products Administration

Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as an adjunctive treatment for partial onset seizures in epilepsy patients 12 years of age and...

North Estonia Medical Centre expands Clinerion’s Patient Network Explorer hospital network in Estonia

North Estonia Medical Centre (NEMC) consists of seven clinics and 32 specialist centers, and is the most important caregiver in the capital of Estonia, Tallinn, as well as in the northern part of the country. As...

A special event organized by Turkish Cargo for IATA CEIV Pharma Workshop

Turkish Cargo organized a Special event titled 'Turkish Cargo & IATA CEIV Pharma Workshop’ for the leading pharmaceutical companies, officials from IATA, agents and business partners. Providing service to 124 countries around the world as one of the fastest growing...

India’s growing biopharma market: monoclonal antibodies R&D and production Designing sterile connection systems

Monoclonal antibodies (MAbs) have been extraordinary tools in the field of bioscience due to their high level of specificity and selective binding ability. Besides its applications in diagnostics, such as the identification of cell surface markers...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read